Sanibel Captiva Trust Company’s Bristol-Myers Squibb BMY Stock Holding History

Sanibel Captiva Trust Company’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.13M	Sell	36,978 -3,743	-9%	-$215K	0.05%	190
2026 Q1	$2.47M	Buy	40,721 +1,584	+4%	+$92.3K	0.07%	175
2025 Q4	$2.11M	Buy	39,137 +1,700	+5%	+$81.8K	0.06%	178
2025 Q3	$1.69M	Buy	37,437 +10,296	+38%	+$481K	0.05%	192
2025 Q2	$1.26M	Sell	27,141 -6,047	-18%	-$297K	0.04%	206
2025 Q1	$2.02M	Sell	33,188 -560	-2%	-$32.6K	0.07%	169
2024 Q4	$1.91M	Sell	33,748 -1,572	-4%	-$87.8K	0.06%	166
2024 Q3	$1.83M	Buy	35,320 +11,315	+47%	+$531K	0.06%	173
2024 Q2	$997K	Buy	24,005 +4,549	+23%	+$204K	0.03%	207
2024 Q1	$1.06M	Sell	19,456 -1,347	-6%	-$68.6K	0.04%	199
2023 Q4	$1.07M	Buy	+20,803	New	+$1.09M	0.04%	186

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Sanibel Captiva Trust Company's BMY Position: Q2 2026 in Review

Sanibel Captiva Trust Company reduced its Bristol-Myers Squibb (BMY) stake by 9.2% in Q2 2026, selling an estimated $215K and leaving 36,978 shares worth $2.13M. The position accounts for 0.05% of the portfolio, ranked #190.

Sanibel Captiva Trust Company first reported a position in BMY in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.47M in Q1 2026. 886 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Sanibel Captiva Trust Company held 36,978 shares of Bristol-Myers Squibb worth $2.13M as of Q2 2026.
Sanibel Captiva Trust Company sold 3,743 Bristol-Myers Squibb shares in Q2 2026, an estimated $215K.
Bristol-Myers Squibb made up 0.05% of Sanibel Captiva Trust Company's portfolio in Q2 2026, its #190 holding.
Sanibel Captiva Trust Company first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 11 quarters since.
Sanibel Captiva Trust Company's Bristol-Myers Squibb position peaked at $2.47M in Q1 2026.
886 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Sanibel Captiva Trust Company's 13F filing for Q2 2026, filed 27 Jul 2026.